Condition: Endovascular Treatment · Chronic Subdural Hematoma · Sponsor: Kazutaka Uchida
COMPLEMENT study (ChrOnic subdural hematoMa Patients suppLemented with Embolization of Middle mENingeal artery Trial) is a prospective, open label, blinded endpoint (PROBE), Japanese, two-arm, randomized, controlled, post-market study to assess the efficacy and safety of middle meningeal artery embolization for chronic subdural hematoma.
This description comes directly from the study's public registry record.
Kazutaka Uchida, MD, PhD · 81+798-45-6458 · fu-sakakibara@hyo-med.ac.jp
Always discuss trial participation with your own doctor first.
| Hyogo Medical University | Nishinomiya, Hyōgo, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06772740